COVID-19 and COPD

Eur Respir J. 2020 Aug 13;56(2):2002108. doi: 10.1183/13993003.02108-2020. Print 2020 Aug.

Abstract

COPD patients have increased risk of severe pneumonia and poor outcomes when they develop COVID-19. This may be related to poor underlying lung reserves or increased expression of ACE-2 receptor in small airways. https://bit.ly/37dSB8l

Publication types

  • Editorial
  • Review

MeSH terms

  • Aged
  • Airway Management / methods
  • Angiotensin-Converting Enzyme 2
  • Biomarkers / blood
  • COVID-19
  • Comorbidity
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / therapy
  • Female
  • Global Health
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Pandemics / statistics & numerical data*
  • Peptidyl-Dipeptidase A / blood*
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / therapy
  • Pulmonary Disease, Chronic Obstructive / diagnosis
  • Pulmonary Disease, Chronic Obstructive / epidemiology*
  • Risk Assessment
  • Severity of Illness Index
  • Smoking / adverse effects
  • Smoking / epidemiology*
  • Vulnerable Populations

Substances

  • Biomarkers
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2